{
    "name": "bisacodyl",
    "comment": "OTC",
    "other_names": [
        "Dulcolax",
        "Correctol",
        "BisacEvac",
        "Bisacolax",
        "Codulax",
        "Alophen",
        "Feen A Mint",
        "Fleet Stimulant Laxative",
        "Laxit",
        "Modane",
        "Dulcolax for Women"
    ],
    "classes": [
        "Laxatives",
        "Stimulant"
    ],
    "source": "https://reference.medscape.com/drug/dulcolax-correctol-bisacodyl-342008",
    "pregnancy": {
        "common": [
            "Plasma concentrations of the active metabolite BHPM are low following doses of 10 mg/day for 7 days; short term use is generally considered safe in pregnancy; avoid long term use"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Not detected in excreted milk following administration of 10 mg/day for 7 days; use with caution"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity",
                "Obstruction or severe impaction",
                "Symptoms of appendicitis or acute surgical abdomen",
                "Vomiting",
                "Rectal bleeding"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Avoid chronic use; may cause laxative dependence",
                "Avoid using in patients with gastroenteritis",
                "Do not chew tablet; swallow whole",
                "Not for use within 1 hour of taking antacid or milk",
                "Not recommended for children < 6 years because of requirement to swallow tablets",
                "Not to be used for >1 week",
                "Some dosage forms may contain benzyl alcohol, which has been associated with fatal toxicity in neonates; avoid dosage forms containing benzyl alcohol derivatives in neonates"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "sodium sulfate/?magnesium sulfate/potassium chloride",
            "description": {
                "common": "sodium sulfate/?magnesium sulfate/potassium chloride increases toxicity of bisacodyl by Other (see comment). Avoid or Use Alternate Drug. \nComment: Coadministration of stimulant laxatives and sodium sulfate/magnesium sulfate/potassium chloride may increase the risk of mucosal ulceration or ischemic colitis."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "sodium sulfate/potassium sulfate/magnesium sulfate",
            "description": {
                "common": "sodium sulfate/potassium sulfate/magnesium sulfate increases toxicity of bisacodyl by Other (see comment). Avoid or Use Alternate Drug. \nComment: Coadministration of stimulant laxatives and sodium sulfate/magnesium sulfate/potassium chloride may increase the risk of mucosal ulceration or ischemic colitis."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "sodium sulfate/potassium sulfate/magnesium sulfate/polyethylene glycol",
            "description": {
                "common": "bisacodyl, sodium sulfate/potassium sulfate/magnesium sulfate/polyethylene glycol.\nEither increases toxicity of the other by Other (see comment). Avoid or Use Alternate Drug. \nComment: Stimulant laxatives may increase the risk of mucosal ulceration or ischemic colitis when coadministered with bowel preps."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "deflazacort",
            "description": {
                "common": "bisacodyl and deflazacort both decrease  serum potassium. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dichlorphenamide",
            "description": {
                "common": "dichlorphenamide and bisacodyl both decrease  serum potassium. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "potassium citrate",
            "description": {
                "common": "bisacodyl decreases levels of potassium citrate by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "potassium acid phosphate",
            "description": {
                "common": "bisacodyl decreases levels of potassium acid phosphate by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "potassium chloride",
            "description": {
                "common": "bisacodyl decreases levels of potassium chloride by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Abdominal cramping",
            "percent": null
        },
        {
            "name": "Electrolyte and fluid imbalance",
            "percent": null
        },
        {
            "name": "Excessive diarrhea",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "Rectal burning",
            "percent": null
        },
        {
            "name": "Vertigo",
            "percent": null
        },
        {
            "name": "Vomiting",
            "percent": null
        }
    ]
}